Pressure Biosciences (PBIO) 0.3320 $PBIO
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
PR Newswire - Tue Jul 22, 6:11AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
and Parabase Genomics ("Parabase" , (together "the companies" , today announced they have entered into a strategic research and development agreement (the "collaboration" . Under the terms of the collaboration, PBI will develop a front-end, sample preparation method for Parabase's enhanced neonatal molecular diagnostics and newborn confirmatory testing process. The sample preparation method will be based on PBI's patented and enabling Pressure Cycling Technology ("PCT" platform.
Pressure BioSciences, Inc. (OTCQB: PBIO) to Present at the FSXinterlinked Investment Conference
PRWeb - Tue Jul 15, 6:08AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the FSXinterlinked Investment Conference being held from July 30th to August 2nd, 2014 at the Four Seasons, Westlake Village, CA.
Pressure BioSciences Inc., ("PBI" (OTCQB: PBIO), Exclusive Interview for Interlinked's Investment News Channel, InterlinkedTV at FSXinterlinked Investment Conference
PRWeb - Tue Jul 01, 6:03PM CDT
Pressure BioSciences Inc., ("PBI" (OTCQB: PBIO) was one of the presenting companies at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Fort Lauderdale, Florida.
Pressure BioSciences Engages IssuWorks in Strategic Advisory Role
PR Newswire - Thu Jun 26, 8:53AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the engagement of IssuWorks to provide strategic advisory services to the Company's board of directors and management team. IssuWorks is the first conflict-free, company-aligned investment bank using technology and services to dramatically improve investor targeting, securities marketing, and distribution in public and private markets. Pressure BioSciences has retained IssuWorks and their management team to review strategic and financing alternatives, including the possible spin-off of vertical market applications into new, stand alone businesses.
Launch of Novel, High Throughput PCT-based Barozyme HT48 System "Very Successful" Says Pressure BioSciences
PR Newswire - Mon Jun 23, 7:16AM CDT
On June 12, 2014, Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" announced the planned launch of their much anticipated, high throughput pressure cycling technology ("PCT" -based system at the 62nd conference of the American Society for Mass Spectrometry ("ASMS" . The ASMS Conference was held June 15-19, 2014 in Baltimore, MD.
Transformative Impact and Adoption of Pressure BioSciences' PCT Platform Prominently Highlighted Throughout Week at Major Scientific Conference
PR Newswire - Thu Jun 19, 10:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that scientists from six separate research groups presented data at the 62nd Annual Conference of the American Society for Mass Spectrometry ("ASMS" being held from June 15-19, 2014 in Baltimore, MD. Study results indicated that utilizing the Company's patented pressure cycling technology ("PCT" platform in the preparation of samples for analysis resulted in critically enabling quality and/or improved time or cost efficiency of test results. These studies were conducted by scientists from ETH Zurich and the University of Zurich ("ETH Zurich" ; Laboratory Corporation of America ("Lab Corp" ; the Food and Drug Administration ("FDA" ; the University of Minnesota ("UMN" , Mayo Clinic, and the Karolinska Instituet; Northeastern University ("NEU" ; and the Baltimore VA Medical Center ("BVAMC" , SAIC-Frederick, National Cancer Institute, and the Veteran's Health Administration.
Pressure BioSciences to Launch Its Much Anticipated High Throughput PCT-based Instrument System (the Barozyme HT48) at the Upcoming ASMS Annual Conference
PR Newswire - Thu Jun 12, 11:43AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced it will launch its high throughput, PCT-based Barozyme HT48 instrument system for the enhanced preparation of proteins for mass spectrometry analysis at the upcoming American Society for Mass Spectrometry ("ASMS" Annual Conference on Mass Spectrometry and Allied Topics. The ASMS Conference is being held June 15-19, 2014 in Baltimore, Maryland.
Pressure BioSciences, Inc. to Present at the Marcum MicroCap Conference
PR Newswire - Wed May 28, 7:41AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29th, at 2:30 pm EDT. The Conference is being held at the Grand Hyatt Hotel in New York City.
SeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014
ACCESSWIRE - Thu May 22, 8:11AM CDT
Conference Being Held at Convene Grand Central in Midtown
Merriman Capital Advisory Clients Presenting at the Third Annual Marcum LLP Microcap Conference
Thomson Reuters ONE - Thu May 22, 8:01AM CDT
SAN FRANCISCO, May 22, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce the firm's advisory clients that will be presenting at the Third Annual Marcum LLP MicroCap Conference. The conference will be held on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
Pressure BioSciences, Inc. Reports Strong Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Tue Apr 01, 9:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the three-month period and fiscal year ended December 31, 2013 and provided a business update.
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2013 Financial Results and Provide a Business Update
PR Newswire - Mon Mar 31, 8:37AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Pressure BioSciences Inc. Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
PRWeb - Fri Mar 21, 3:37PM CDT
Pressure BioSciences Inc. was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Dallas, Texas.
Pressure BioSciences Announces the Release and Initial Sale of the Barocycler HUB880, a "First-in-Kind" Ultra High Pressure Bench-top Instrument System
PR Newswire - Wed Mar 19, 9:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also announced the sale (and shipment) of its first HUB880 system to Dr. Wayne Hubbell of the University of California Los Angeles (UCLA). PBI plans to showcase the HUB880 at the upcoming U.S. Human Proteome Organization's 10th Annual Conference to be held at the Westin-Seattle (WA), April 6-9, 2014.
Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA" . The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom.
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
PR Newswire - Tue Jul 22, 6:11AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
and Parabase Genomics ("Parabase" , (together "the companies" , today announced they have entered into a strategic research and development agreement (the "collaboration" . Under the terms of the collaboration, PBI will develop a front-end, sample preparation method for Parabase's enhanced neonatal molecular diagnostics and newborn confirmatory testing process. The sample preparation method will be based on PBI's patented and enabling Pressure Cycling Technology ("PCT" platform. Pressure BioSciences, Inc. (OTCQB: PBIO) to Present at the FSXinterlinked Investment Conference
PRWeb - Tue Jul 15, 6:08AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the FSXinterlinked Investment Conference being held from July 30th to August 2nd, 2014 at the Four Seasons, Westlake Village, CA. Pressure BioSciences Inc., ("PBI"
(OTCQB: PBIO), Exclusive Interview for Interlinked's Investment News Channel, InterlinkedTV at FSXinterlinked Investment Conference PRWeb - Tue Jul 01, 6:03PM CDT
Pressure BioSciences Inc., ("PBI"
(OTCQB: PBIO) was one of the presenting companies at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Fort Lauderdale, Florida. Pressure BioSciences Engages IssuWorks in Strategic Advisory Role
PR Newswire - Thu Jun 26, 8:53AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced the engagement of IssuWorks to provide strategic advisory services to the Company's board of directors and management team. IssuWorks is the first conflict-free, company-aligned investment bank using technology and services to dramatically improve investor targeting, securities marketing, and distribution in public and private markets. Pressure BioSciences has retained IssuWorks and their management team to review strategic and financing alternatives, including the possible spin-off of vertical market applications into new, stand alone businesses. Launch of Novel, High Throughput PCT-based Barozyme HT48 System "Very Successful" Says Pressure BioSciences
PR Newswire - Mon Jun 23, 7:16AM CDT
On June 12, 2014, Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
announced the planned launch of their much anticipated, high throughput pressure cycling technology ("PCT" -based system at the 62nd conference of the American Society for Mass Spectrometry ("ASMS" . The ASMS Conference was held June 15-19, 2014 in Baltimore, MD. Transformative Impact and Adoption of Pressure BioSciences' PCT Platform Prominently Highlighted Throughout Week at Major Scientific Conference
PR Newswire - Thu Jun 19, 10:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that scientists from six separate research groups presented data at the 62nd Annual Conference of the American Society for Mass Spectrometry ("ASMS" being held from June 15-19, 2014 in Baltimore, MD. Study results indicated that utilizing the Company's patented pressure cycling technology ("PCT" platform in the preparation of samples for analysis resulted in critically enabling quality and/or improved time or cost efficiency of test results. These studies were conducted by scientists from ETH Zurich and the University of Zurich ("ETH Zurich" ; Laboratory Corporation of America ("Lab Corp" ; the Food and Drug Administration ("FDA" ; the University of Minnesota ("UMN" , Mayo Clinic, and the Karolinska Instituet; Northeastern University ("NEU" ; and the Baltimore VA Medical Center ("BVAMC" , SAIC-Frederick, National Cancer Institute, and the Veteran's Health Administration. Pressure BioSciences to Launch Its Much Anticipated High Throughput PCT-based Instrument System (the Barozyme HT48) at the Upcoming ASMS Annual Conference
PR Newswire - Thu Jun 12, 11:43AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced it will launch its high throughput, PCT-based Barozyme HT48 instrument system for the enhanced preparation of proteins for mass spectrometry analysis at the upcoming American Society for Mass Spectrometry ("ASMS" Annual Conference on Mass Spectrometry and Allied Topics. The ASMS Conference is being held June 15-19, 2014 in Baltimore, Maryland. Pressure BioSciences, Inc. to Present at the Marcum MicroCap Conference
PR Newswire - Wed May 28, 7:41AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29th, at 2:30 pm EDT. The Conference is being held at the Grand Hyatt Hotel in New York City. SeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014
ACCESSWIRE - Thu May 22, 8:11AM CDT
Conference Being Held at Convene Grand Central in Midtown
Merriman Capital Advisory Clients Presenting at the Third Annual Marcum LLP Microcap Conference
Thomson Reuters ONE - Thu May 22, 8:01AM CDT
SAN FRANCISCO, May 22, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce the firm's advisory clients that will be presenting at the Third Annual Marcum LLP MicroCap Conference. The conference will be held on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
Pressure BioSciences, Inc. Reports Strong Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Tue Apr 01, 9:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced financial results for the three-month period and fiscal year ended December 31, 2013 and provided a business update. Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2013 Financial Results and Provide a Business Update
PR Newswire - Mon Mar 31, 8:37AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"
today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below: Pressure BioSciences Inc. Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
PRWeb - Fri Mar 21, 3:37PM CDT
Pressure BioSciences Inc. was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Dallas, Texas.
Pressure BioSciences Announces the Release and Initial Sale of the Barocycler HUB880, a "First-in-Kind" Ultra High Pressure Bench-top Instrument System
PR Newswire - Wed Mar 19, 9:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also announced the sale (and shipment) of its first HUB880 system to Dr. Wayne Hubbell of the University of California Los Angeles (UCLA). PBI plans to showcase the HUB880 at the upcoming U.S. Human Proteome Organization's 10th Annual Conference to be held at the Westin-Seattle (WA), April 6-9, 2014. Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA" . The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom. 
